glp-1 news employers Perspectives from on the costs and issues associated with covering agonists for weight loss GLP-1 Coverage in Employer Plans

The FDA's Pharmacy Compounding Advisory Committee is scheduled to meet next month to discuss the following seven unregulated peptides: July 23, 2026: BPC-157, KPV, TB-500, and MOTS-c

Mountjoy PD, Bailey SJ, Rutter GA

Initial discussions should also include issues around lifestyle (nutrition, weight loss, and physical activity) and the possible treatment of obesity, such as using the American Association of Clinical Endocrinologists Obesity Treatment Algorithm, which may include obesity pharmacotherapy [14]

Your gut health is the foundation of your transformation

I CARNITINE - MetCon L CARN is the most effective all-natural non-stimulant blend of L-Carnitine on the market

Peer review Peer review information Nature Communications thanks Isaac Harris, Jenny Y